Position in BHVN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$445,782
-$149,121 QoQ
Shares Held
52,693
0.0% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kennondale Capital Management LLC holds $1,562,621 across 2 Biotechnology names. BHVN ranks #2 (28.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
|
318,188 | $1,116,839 | |
| 2 | BHVN |
Biohaven Ltd.
This page
|
52,693 | $445,782 |
All Filings in BHVN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $445,782 | 52,693 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $594,903 | 52,693 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||